Clinical trial
A Pilot Study of Low Dose IL-2 in the Treatment of Relapsing Polychondritis
NCT04077736 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study of Low Dose IL-2 in the Treatment of Relapsing Polychondritis
- Lead sponsor
- Peking University People's Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 1, 2019
- Completion date
- October 30, 2023
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
relapsing polychondritis